Related references
Note: Only part of the references are listed.Perinatal outcomes in women living with HIV-1 and receiving antiretroviral therapy-a systematic review and meta-analysis
Shiri Shinar et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2022)
The assessment of blood pressure in pregnant women: pitfalls and novel approaches
Alice Hurrell et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)
Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy
Amanda J. Jones et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2022)
Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial
Kristin Baltrusaitis et al.
BMC INFECTIOUS DISEASES (2022)
Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement
Ahizechukwu C. Eke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Assessing causality in epidemiology: revisiting Bradford Hill to incorporate developments in causal thinking
Michal Shimonovich et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)
HIV in pregnancy - An update
Victor N. Chilaka et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2021)
Tenofovir, pregnancy and renal function changes in pregnant women living with HIV
Matthew A. Thimm et al.
AIDS (2021)
High Stillbirth Rate among Human Immunodeficiency Virus-Infected Pregnant Women in West Bengal, India: a Retrospective Cohort Study
Suman Ganguly et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2021)
Ethical considerations for research involving pregnant women living with HIV and their young children: a systematic review of the empiric literature and discussion
Catherine G. Raciti et al.
BMC MEDICAL ETHICS (2021)
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Shahin Lockman et al.
LANCET (2021)
Adverse Pregnancy Outcomes Among HIV-positive Women in the Era of Universal Antiretroviral Therapy Remain Elevated Compared With HIV-negative Women
Vincent J. Tukei et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)
The Role of HIV Infection in the Pathophysiology of Gestational Diabetes Mellitus and Hypertensive Disorders of Pregnancy
Wendy N. Phoswa
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B plus in Uganda: an observational study nested within a randomized controlled trial
Grace Gabagaya et al.
BMC INFECTIOUS DISEASES (2021)
Screening for Gestational Diabetes US Preventive Services Task Force Recommendation Statement
Karina W. Davidson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana
Rebecca Zash et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2021)
Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial
Joan T. Price et al.
LANCET HIV (2021)
Does antiretroviral therapy cause congenital malformations? A systematic review and meta-analysis
Fekadu Mazengia Alemu et al.
EPIDEMIOLOGY AND HEALTH (2021)
Stillbirth outcome capture and classification in population-based surveys: EN-INDEPTH study
Hannah Blencowe et al.
POPULATION HEALTH METRICS (2021)
Measuring Health Outcomes in HIV: Time to Bring in the Patient Experience
Niki O'Brien et al.
ANNALS OF GLOBAL HEALTH (2021)
Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement
Ahizechukwu C. Eke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Investigation of factors associated with spontaneous preterm birth in pregnant women living with HIV
Arianne Y. K. Albert et al.
AIDS (2020)
Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy
Ahizechukwu C. Eke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Time of HIV diagnosis, CD4 count and viral load at antenatal care start and delivery in South Africa
Dorina Onoya et al.
PLOS ONE (2020)
Darunavir Pharmacokinetics With an Increased Dose During Pregnancy
Ahizechukwu C. Eke et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2020)
Mid-trimester cervical length not associated with HIV status among pregnant women in Botswana
Ingrid Liff et al.
PLOS ONE (2020)
Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV
Ahizechukwu C. Eke et al.
CLINICAL PHARMACOKINETICS (2020)
Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study
Gerson Fernando Mendes Pereira et al.
Lancet HIV (2020)
Timing of combination antiretroviral therapy (cART) initiation is not associated with stillbirth among HIV-infected pregnant women in Malawi
Malango T. Msukwa et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2019)
HIV serostatus, viral load, and midtrimester cervical length in a Zambian prenatal cohort
Joan T. Price et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2019)
Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir
Vani Vannappagari et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2019)
Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: A systematic review
Ashish Premkumar et al.
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2019)
Congenital anomalies following antenatal exposure to dolutegravir: a Canadian surveillance study
D. Money et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2019)
Gestational diabetes mellitus in HIV-infected pregnant women: A systematic review and meta-analysis
Belete Biadgo et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis
Kartik Kailas Venkatesh et al.
AIDS (2019)
Combination Antiretroviral Therapy and Hypertensive Disorders of Pregnancy
Michele K. Saums et al.
OBSTETRICS AND GYNECOLOGY (2019)
Choosing primary endpoints for clinical trials of health care interventions
Charlie McLeod et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2019)
Hypertension in pregnancy: Pathophysiology and treatment
Stephanie Braunthal et al.
SAGE OPEN MEDICINE (2019)
Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age
Ingrid J. M. Snijdewind et al.
PLOS ONE (2018)
Pregnancy outcomes among H IV-infected women who conceived on antiretroviral therapy
Elizabeth M. Stringer et al.
PLOS ONE (2018)
The association between HIV, antiretroviral therapy, and gestational diabetes mellitus
Larske M. Soepnel et al.
AIDS (2017)
HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods
Lynn T. Matthews et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review
Gali Pariente et al.
PLOS MEDICINE (2016)
Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis
Chrystelle O. O. Wedi et al.
LANCET HIV (2016)
PRETERM BIRTH AND FETAL GROWTH RESTRICTION IN HIV-INFECTED BRAZILIAN PREGNANT WOMEN
Helena Lucia Barroso Dos Reis et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2015)
Congenital Anomalies and In Utero Antiretroviral Exposure in Human Immunodeficiency Virus-Exposed Uninfected Infants
Paige L. Williams et al.
JAMA PEDIATRICS (2015)
Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis
Nathan Ford et al.
AIDS (2014)
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011
Claire L. Townsend et al.
AIDS (2014)
Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected Patients
Patrick Ryscavage et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A Prospective Study of the Effect of Pregnancy on CD4 Counts and Plasma HIV-1 RNA Concentrations of Antiretroviral-Naive HIV-1-Infected Women
Renee Heffron et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Risk Factors for Preterm Birth Among HIV-Infected Pregnant Ugandan Women Randomized to Lopinavir/Ritonavir- or Efavirenz-Based Antiretroviral Therapy
Catherine A. Koss et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Comparative Performances of HIV-1 RNA Load Assays at Low Viral Load Levels: Results of an International Collaboration
Luke C. Swenson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria
Bohdan Nosyk et al.
AIDS (2013)
Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010
Nelly Briand et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ?
Karoline Aebi-Popp et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2013)
Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia
Gudrun Naeth et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2013)
Small for gestational age birth outcomes in pregnant women with perinatally acquired HIV
Jennifer Jao et al.
AIDS (2012)
Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women
Hae-Young Kim et al.
BMC PEDIATRICS (2012)
The Association Between HIV/AIDS During Pregnancy and Fetal Growth Parameters in Florida: A Population Based Study
Hamisu M. Salihu et al.
CURRENT HIV RESEARCH (2012)
The HIV-1 Epidemic: Low- to Middle-Income Countries
Yiming Shao et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
National Diabetes Data Group vs Carpenter-Coustan criteria to diagnose gestational diabetes
Erica K. Berggren et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification
Celine S. Yan et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
Viral load assay sensitivity and low level viremia in HAART treated HIV patients
Chris Verhofstede et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
Birth Defects Among Children Born to Human Immunodeficiency Virus-Infected Women Pediatric AIDS Clinical Trials Protocols 219 and 219C
Susan B. Brogly et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission
Amparo Garcia-Tejedor et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2009)
Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure
David W. Ouyang et al.
AIDS (2009)
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate
PJ Meis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
